Lillian Castriotta

<i>Helicobacter pylori</i>Infection in Immunized Mice Lacking Major Histocompatibility Complex Class I and Class II Functions

Jacques Pappo, Deirdre Torrey, Lillian Castriotta et al. · Infection and Immunity · 1999 · 152 citations · Full text

Histocompatibility, Class Ii Functions, Microbial Pathogens +17

AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies

Garrett W. Rhyasen, Maureen M. Hattersley, Yi Yao et al. · Molecular Cancer Therapeutics · 2016 · 147 citations · Full text

Azd5153 Exposure, Pathology, Pharmacotherapy +17

Discovery of a Novel Class of Dimeric Smac Mimetics as Potent IAP Antagonists Resulting in a Clinical Candidate for the Treatment of Cancer (AZD5582)

Edward J. Hennessy, Ammar Adam, Brian Aquila et al. · Journal of Medicinal Chemistry · 2013 · 112 citations · Full text

Compound 14, Apoptosis, Cell Death +18

Inhibition of PI3Kβ Signaling with AZD8186 Inhibits Growth of PTEN-Deficient Breast and Prostate Tumors Alone and in Combination with Docetaxel

Urs J. Hancox, Sabina Cosulich, Lyndsey Hanson et al. · Molecular Cancer Therapeutics · 2014 · 99 citations · Full text

BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors

Garrett W. Rhyasen, Yi Yao, Jingwen Zhang et al. · PLoS ONE · 2018 · 54 citations · Full text

Confers Sensitivity, Brd4 Amplification, Bet Inhibitors +16